A Breathalyzer Test for Cancer?
September 17, 2026
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Visiting Israel? Visit the Technion.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreColonoscopy Screening Just Got Smarter
As Seen in nocamels.com
Israeli AI-assisted colonoscopy technology has been given the seal of approval from the internationally respected Lancet Digital Health (opens in a new tab) journal, following an extensive study of its capabilities.
The novel polyp detection system developed by Haifa-based MAGENTIQ-EYE (opens in a new tab) was studied by the Lancet over a 14-month period at 10 leading medical centers around the world, involving 31 endoscopists and 952 patients.
The study (opens in a new tab), titled “A computer-aided polyp detection system in screening and surveillance colonoscopy: an international, multicentre, randomised, tandem trial,” found that the MAGNETIQ-EYE platform increases the average detection rate for adenoma (non-cancerous or pre-cancerous tumors) by 7 percent, and had a 17-percent lower rate of missed detection of adenoma.
MAGNETIQ-EYE CEO Dror Zur is a Technion alumnus.
Related Stories